MaxCyte IPO Presentation Deck

The VLX: Enabling Large Scale Bioprocessing VLX VLX Instrument Specifically designed for extremely large volume cell-engineering July 2021 Capacity to transfect up to 200 billion cells in less than 30 minutes - 10 times the capacity of the GTX In beta testing for large scale bioprocessing applications Key Applications 3 · Up to 200 billion cells VLx in < 30 minutes Future Recombinant proteins Viral vector · · expert™ VLx Instrument Working towards launching the VLX under the EXPERTTM brand CONFIDENTIAL Ease-of-use and cell handling improvements cGMP compliance GMP consumables Virus-like particles (VLPs) Allogeneic cell therapies Vaccines

View entire presentation